Kiran Aher (6 results)

Author: 
Refine with Advanced Search

Refine your search

  • Books (6)

  • New (6)

to

Custom price range (£)

to

  • Language: English

    Published by LAP LAMBERT Academic Publishing, 2018

    3659712914 / 9783659712913

    • Softcover

    Seller: preigu, Osnabrück, Germanypreigu

    5-star seller
    Contact seller

    Condition: New

    £ 64.80

    £ 60.00 shipping 
    Ships from Germany to U.S.A.

    Quantity: 5 available

    Taschenbuch. Condition: Neu. Designing of Oral Sustained Release Bioadhesive Drug Delivery System | for NSAID's | Kiran Aher (u. a.) | Taschenbuch | 336 S. | Englisch | 2018 | LAP LAMBERT Academic Publishing | EAN 9783659712913 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.…

  • Language: English

    Published by LAP LAMBERT Academic Publishing, 2018

    3659712914 / 9783659712913

    • Softcover

    Seller: Revaluation Books, Exeter, United KingdomRevaluation Books

    5-star seller
    Contact seller

    Condition: New

    £ 128.68

    £ 12.50 shipping 
    Ships from United Kingdom to U.S.A.

    Quantity: 1 available

    Paperback. Condition: Brand New. 336 pages. 8.66x5.91x0.76 inches. In Stock.

  • Language: English

    Published by LAP LAMBERT Academic Publishing Sep 2018, 2018

    3659712914 / 9783659712913

    • Softcover
    • Print on Demand

    Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermanyBuchWeltWeit Ludwig Meier e.K.

    5-star seller
    Contact seller

    Condition: New

    £ 77.61

    £ 19.72 shipping 
    Ships from Germany to U.S.A.

    Quantity: 2 available

    Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The objective of the present study was to develop 'once daily' sustained-release bioadhesive tablet of Zaltoprofen (ZLT) and Lornoxicam (LXM) which will deliver the drug it in small doses over an extended period and localizing it in the intestine by bioadhesion. ZLT is a new non-steroidal anti-inflammatory drug which has anti-inflammatory, analgesic and antipyretic effect and frequently used for rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute gout. ZLT has short biological half-life (4.96 - 7.48h) and blood drug level decrease in short time so that patients need frequent administration (t.i.d). The sustained-release polymers, hydroxypropyl methylcellulose (HPMC) of different viscosities and xanthan gum evaluated in different proportions as a major matrix material. Drug-polymer compatibility studies by FTIR and DSC gave confirmation about their purity and showed no interaction physically between drug and selected polymers. ZLT matrix tablets were prepared by wet granulation. The effect of polymer concentration on the drug release profile and in-vitro bioadhesion of the matrix tablets was studied. 336 pp. Englisch.…

  • Language: English

    Published by LAP LAMBERT Academic Publishing, 2018

    3659712914 / 9783659712913

    • Softcover
    • Print on Demand

    Seller: moluna, Greven, Germanymoluna

    5-star seller
    Contact seller

    Condition: New

    £ 61.85

    £ 41.99 shipping 
    Ships from Germany to U.S.A.

    Quantity: Over 20 available

    Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Aher KiranDr. Kiran Aher., M. Pharm, PhD (QAT) obtained his Bachelors (2004) and Masters degree (2006) from Pune University, Pune. He was a gold medalist at Masters Level. He has been awarded with PhD in Pharmaceutical Sciences from . …

  • Language: English

    Published by LAP LAMBERT Academic Publishing Sep 2018, 2018

    3659712914 / 9783659712913

    • Softcover
    • Print on Demand

    Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germanybuchversandmimpf2000

    5-star seller
    Contact seller

    Condition: New

    £ 77.61

    £ 51.43 shipping 
    Ships from Germany to U.S.A.

    Quantity: 1 available

    Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The objective of the present study was to develop 'once daily' sustained-release bioadhesive tablet of Zaltoprofen (ZLT) and Lornoxicam (LXM) which will deliver the drug it in small doses over an extended period and localizing it in the intestine by bioadhesion. ZLT is a new non-steroidal anti-inflammatory drug which has anti-inflammatory, analgesic and antipyretic effect and frequently used for rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute gout. ZLT has short biological half-life (4.96 - 7.48h) and blood drug level decrease in short time so that patients need frequent administration (t.i.d). The sustained-release polymers, hydroxypropyl methylcellulose (HPMC) of different viscosities and xanthan gum evaluated in different proportions as a major matrix material. Drug-polymer compatibility studies by FTIR and DSC gave confirmation about their purity and showed no interaction physically between drug and selected polymers. ZLT matrix tablets were prepared by wet granulation. The effect of polymer concentration on the drug release profile and in-vitro bioadhesion of the matrix tablets was studied.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 336 pp. Englisch.…

  • Language: English

    Published by LAP LAMBERT Academic Publishing, 2018

    3659712914 / 9783659712913

    • Softcover
    • Print on Demand

    Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH

    5-star seller
    Contact seller

    Condition: New

    £ 77.61

    £ 53.65 shipping 
    Ships from Germany to U.S.A.

    Quantity: 1 available

    Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The objective of the present study was to develop 'once daily' sustained-release bioadhesive tablet of Zaltoprofen (ZLT) and Lornoxicam (LXM) which will deliver the drug it in small doses over an extended period and localizing it in the intestine by bioadhesion. ZLT is a new non-steroidal anti-inflammatory drug which has anti-inflammatory, analgesic and antipyretic effect and frequently used for rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute gout. ZLT has short biological half-life (4.96 - 7.48h) and blood drug level decrease in short time so that patients need frequent administration (t.i.d). The sustained-release polymers, hydroxypropyl methylcellulose (HPMC) of different viscosities and xanthan gum evaluated in different proportions as a major matrix material. Drug-polymer compatibility studies by FTIR and DSC gave confirmation about their purity and showed no interaction physically between drug and selected polymers. ZLT matrix tablets were prepared by wet granulation. The effect of polymer concentration on the drug release profile and in-vitro bioadhesion of the matrix tablets was studied.…